Clinical Trials Logo
  1. Home
  2. Kidney Transplantation
  3. NCT05142748
  4. Details
NCT05142748 Clinical Trial

Study of Pulmonary Infections (Pneumonia) in Kidney Transplant Recipients Admitted to Hospital

Kidney Transplant Infection Clinical Trial

Official title:
Study of Pulmonary Infections (Pneumonia) in Kidney Transplant Recipients Admitted to Hospital

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT05142748
Other study ID # 2021Ao001
Secondary ID
Status Completed
Phase
First received
Last updated
Start date September 1, 2019
Est. completion date November 30, 2020

Study information
Verified date September 2022
Source CHU de Reims
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The investigators aimed to identify prognosis factors associated with in-hospital complications and assess the epidemiology, management, and outcomes of community-acquired pneumonia in a kidney transplant recipients' cohort. The investigators intend to identify each stay by a national database. Then they will be consulted by 2 clinicians to assert CAP clinical definition. After that radiographic evidence will be reviewed to validate CAP diagnoses. Then clinical data are collected in each center.

Recruitment information / eligibility
Status Completed
Enrollment 132
Est. completion date November 30, 2020
Est. primary completion date November 30, 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - kidney transplant recipients - at least 18 years - admitted to hospital for CAP. Non-inclusion criteria were: Exclusion Criteria: - incomplete CAP definition - hospital-acquired pneumonia - another diagnosis explaining the symptoms - patients with non-functional kidney graft

Study Design

Related Conditions & MeSH terms

Locations
Country Name City State
France Chu Reims Reims

Sponsors (1)
Lead Sponsor Collaborator
CHU de Reims

Country where clinical trial is conducted

France, 

Outcome
Type Measure Description Time frame Safety issue
Primary In-hospital complications In-hospital death, transfer to intensive care units (ICU) and prolonged stays inhospital stay, an average of 30 days
See also
  Status Clinical Trial Phase
Terminated NCT02439957 - A Phase 3 Study of Brincidofovir Versus Valganciclovir for the Prevention of Cytomegalovirus Phase 3
Not yet recruiting NCT06364618 - Use of Wearables to Detect Infections in Kidney Transplant Recipients
Terminated NCT05747053 - Personalization of Immunosuppressive Treatment for Organ Transplant Recipients
Completed NCT03339661 - Secondary Prophylaxis After CMV Disease in Kidney Transplant Patients Targeted by γδ T Cells Immunomonitoring. Phase 2
Enrolling by invitation NCT05224583 - Prevalence of BK Viremia in Simultaneous Liver-Kidney Transplant
Recruiting NCT04701528 - Anti-Viral Effects of Voclosporin in COVID-19 Positive Kidney Transplant Recipients Phase 2
Recruiting NCT04494776 - SARS-COV-2 Infection in Kidney Transplant Recipients: a Brazilian Multicenter Study
Completed NCT02263703 - Immunogenicity of HPV Vaccine in Immunosuppressed Children Phase 3
Recruiting NCT06219616 - Prediction of BK Virus Reactivation in Kidney Transplant Recipient N/A
Not yet recruiting NCT05708534 - Evolution of CMV Antiviral T-cell Immunity Over the Next Six Months Initiation of Treatment With Belatacept.
Recruiting NCT03488771 - Evaluation of Cell-mediated Immune Response by QuantiFERON Monitor® Assay in Kidney Transplant Recipients
Recruiting NCT04815954 - Early vs Late Urinary Catheter Removal After Renal Transplantation N/A
Recruiting NCT05727709 - Dynamic Changes of Torquetenovirus (TTV) Load in Chinese Renal Transplant Recipients
Completed NCT04542954 - Optimized Management of Covid-19 Positive Kidney Transplant Recipients: Single Center Experience From the Middle East
Active, not recruiting NCT03924219 - CMV T Cell Immunity in Pediatric Solid Organ Transplant Recipients
Recruiting NCT05836636 - Immune Monitoring of Prevalent Kidney Transplant Recipients Using Torque Teno Virus: A Single-Center, Prospective Cohort Study
Completed NCT03468478 - Comparison of the Efficacy and Safety of Sirolimus Versus Everolimus Versus Mycophenolate in Kidney Transplantation Phase 4
Recruiting NCT05397821 - Pediatric Kidney Transplantation, Ureteroneocystostomy Techniques
Not yet recruiting NCT05316038 - Metabolic and Infectious Complications Post Belatacept Conversion
Active, not recruiting NCT04747522 - Severe Acute Respiratory Syndrome Corona Virus 2 (SARS-CoV-2) Immune Kidney Transplant Study (COVID-19)